Victory Capital Management
CALA

Victory Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Victory Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-583
Closed -$3K – 2779
2022
Q1 		$3K Buy
+583
New +$5.96K ﹤0.01% 2721
2020
Q3 		– Sell
-515
Closed -$54K – 2590
2020
Q2 		$54K Sell
515
-544
-51% -$64.6K ﹤0.01% 2395
2020
Q1 		$94K Buy
+1,059
New +$126K ﹤0.01% 2554
2019
Q4 		– Sell
-405
Closed -$25K – 3546
2019
Q3 		$25K Buy
+405
New +$32.4K ﹤0.01% 2970
2018
Q1 		– Sell
-4,486
Closed -$749K – 1945
2017
Q4 		$749K Sell
4,486
-378
-8% -$96.8K ﹤0.01% 1277
2017
Q3 		$1.53M Sell
4,864
-137
-3% -$43.2K ﹤0.01% 1093
2017
Q2 		$1.49M Sell
5,001
-56
-1% -$15K ﹤0.01% 1056
2017
Q1 		$1.17M Buy
+5,057
New +$874K ﹤0.01% 1113

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's CALA Position: Q2 2022 in Review

Victory Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 583 shares — an estimated $3K sold.

Victory Capital Management first reported a position in CALA in Q1 2017 and held it in 8 quarters. The position peaked at $1.53M in Q3 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Victory Capital Management reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Victory Capital Management sold 583 Calithera Biosciences, Inc shares in Q2 2022, an estimated $3K.
  • Victory Capital Management first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 8 quarters.
  • Victory Capital Management's Calithera Biosciences, Inc position peaked at $1.53M in Q3 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.